Macro Dragon: +15K Cases In China, Put a Fork in Biden - perhaps even Warren?

Macro Dragon: +15K Cases In China, Put a Fork in Biden - perhaps even Warren?

Macro 2 minutes to read
Kay Van-Petersen

Global Macro Strategist

Summary:  As the Asia Thu morning start, we got news that have taken Equity Futures from green to red, with S&P futures currently down -0.30% on the news that we have potentially c. +15,000 new cases found in the province of Hubei - due to revised testing methods. This would take the confirmed cases to 60,000, which is on track to get to the 7 figures that we have been extrapolating on, since the 2019-nCoV now formally called Covid-19 kicked off. We also check in on US politics - put a fork in Biden! And see some central bankers comment on the virus as well as China stimulus.


(These are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations. By the time you synthesize this, things may have changed.)

2020-Feb-13

 

Macro Dragon:+15K New Virus Cases + Put a fork in Biden & perhaps also Warren?

 

US Elections Checks in & Other Thoughts…

  • Bernie took NH, with Buttigieg close on his heels… As has been flagged to KVP (& believe we mentioned that IO & NH are very white states), Buttigieg base seems to be progressive, wealthy white folks, with actually very little traction on millennials despite at 38 him being much younger than the rest of the field. Millennials love ‘The Bern’. Klobuchar likely also took some wind out of Buttigieg sales (lucky for Sanders), yet she came in above Warren.
  • Unless Bernie stumbles any time soon (Unlikely), Warren is likely done – some massive time decay on that vehicle. Buttigieg & Klobuchar are likely going to struggle again the non-white base, as well as the less wealthy… stay tuned.
  • Meanwhile markets don’t really seem to care on any risk of a Sanders nomination – whether that’s because its priced correctly (i.e. he has not chance), its too early in the cycle & is not dominating enough, Trump has it in the bag, etc… too early to tell.

 

Covid-19 Update Thu Asia Mrn 12 Feb & Thoughts…

 

Quick update & thoughts on the Virus since the Yest’s check in:

  • As of this Wed 13 Asia morning, the China figures we are getting are at c. 45,200 confirmed cases, +1120 deaths & +5,150 recovered. So suggesting a considerable slowdown in confirmed cases in China & big uptick in those recovering.   
  • However a breaking news headline suggest that we may need to add up to +15,000 new cases stemming from the province of Hubei (60m people), given new methods used to test & screen for the coronavirus
  • This has sent S&P futures from positive territory to c. -0.40% to -0.50% lower this early morning Asia. If this is true, that would take confirmed cases in China to +60,000. As the Macro Dragon have conservatively stipulated before, given the population & seasonal dynamics of China – we likely get into the 6 figures before the Covid-19 is fully contained. And again 60,000 in a province of 60m (funnily enough the number of Americans infected with the H1N1 swine flu virus that broke out in the US in 2009), is only 0.10%.
  • One last point, a lot of countries are starting to put restrictions on travel to places like Singapore – this again is the paradox of circles of silence (just because the data is not there, does not mean there is no data). What people should be instead thinking is, if Singapore with its incredible experience, resources & organization honed through SARs has found these 50 cases, what is the “REAL” case count in other countries? i.e. Indonesia with 230m, Thailand with 70m, all whom also do a tremendous amount of business & travel with China.
  • Obviously an element of this is political – you have to be seen to be doing something, regardless of whether that action is actually fruitful or futile.
  • BoC’s Poloz is saying to early to really process the effects of the virus. And RBA’s Lowe point out that China has indicated that they will stimulate which should be good for the Australian economy. You have to wonder whether we could see an RBA similar to RBNZ o/n which did not cut rates as per expectations, yet seemed to signal that there would be no cuts in 2020 – sending the kiwi higher against crosses, there could be quite a bit of juice left here over the year (i.e. get to the other side of CH data gaining).

Outside of China the countries with confirmed cases over 10 are:

  • Japan 202 (174 from the cruise ship)
  • Hong Kong 50 (+1)
  • Singapore 50 (+3)
  • Thailand 33 (+1)
  • South Korea 28
  • Taiwan 18
  • Malaysia 18
  • Germany 16
  • Australia 15
  • Vietnam 15
  • United States 13 (+1)
  • France 11
  • Macau 10

      -

       

      Have a fantastic, gratitude & abundant filled close to the wk everyone, stay healthy as well as keep your mind open to profitable & abundant opportunities. Life happens for us, not to us.  


      Namaste,

      -KVP

      -

      Some Anchor Pieces from #SaxoStrats:

      Quarterly Outlook

      01 /

      • Equity outlook: The high cost of global fragmentation for US portfolios

        Quarterly Outlook

        Equity outlook: The high cost of global fragmentation for US portfolios

        Charu Chanana

        Chief Investment Strategist

      • Commodity Outlook: Commodities rally despite global uncertainty

        Quarterly Outlook

        Commodity Outlook: Commodities rally despite global uncertainty

        Ole Hansen

        Head of Commodity Strategy

      • Upending the global order at blinding speed

        Quarterly Outlook

        Upending the global order at blinding speed

        John J. Hardy

        Global Head of Macro Strategy

        We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
      • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

        Quarterly Outlook

        Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

        Jacob Falkencrone

        Global Head of Investment Strategy

      • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

        Quarterly Outlook

        Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

        John J. Hardy

        Global Head of Macro Strategy

      • Equity Outlook: The ride just got rougher

        Quarterly Outlook

        Equity Outlook: The ride just got rougher

        Charu Chanana

        Chief Investment Strategist

      • China Outlook: The choice between retaliation or de-escalation

        Quarterly Outlook

        China Outlook: The choice between retaliation or de-escalation

        Charu Chanana

        Chief Investment Strategist

      • Commodity Outlook: A bumpy road ahead calls for diversification

        Quarterly Outlook

        Commodity Outlook: A bumpy road ahead calls for diversification

        Ole Hansen

        Head of Commodity Strategy

      • FX outlook: Tariffs drive USD strength, until...?

        Quarterly Outlook

        FX outlook: Tariffs drive USD strength, until...?

        John J. Hardy

        Global Head of Macro Strategy

      • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

        Quarterly Outlook

        Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

        Althea Spinozzi

        Head of Fixed Income Strategy

      None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

      Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

      Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

      Please refer to our full disclaimer for more details.

      Saxo
      40 Bank Street, 26th floor
      E14 5DA
      London
      United Kingdom

      Contact Saxo

      Select region

      United Kingdom
      United Kingdom

      Trade Responsibly
      All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
      Additional Key Information Documents are available in our trading platform.

      Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

      This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

      It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

      Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

      ©   since 1992